Open AccessSustained benefit at 10–14 years follow-up after thrombolytic therapy in myocardial infarction
Author(s) -
Arthur Maas
Publication year - 1999
Publication title -
european heart journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.336
H-Index - 293
eISSN - 1522-9645
pISSN - 0195-668X
DOI - 10.1053/euhj.1998.1443
Subject(s) - medicine , streptokinase , myocardial infarction , randomized controlled trial , fibrinolytic agent , cardiology , intensive care medicine , tissue plasminogen activator
To investigate whether the benefit of thrombolytic therapy was sustained beyond the first decade. We report the 10-14 year outcome of 533 patients who were randomized to treatment with intracoronary streptokinase or to conventional therapy during the years 1980-1985.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom